Skip to main content
Fig. 4 | Renal Replacement Therapy

Fig. 4

From: Severe hypoglycemia during pneumocystis pneumonia treatment associated with trimethoprim–sulfamethoxazole use in a patient on peritoneal dialysis

Fig. 4

RT-CGM results from days 16 to 21. The patient exhibited hypoglycemia again on the morning of day 17 (boxed by the dotted line, magnified on the lower right). The amount of glucose infusion was reduced by gradually adjusting the injection rate of 50% glucose fluid. *Time is written as military time (commonly used in Japan). RT-CGM: real-time continuous glucose monitoring, TMP/SMX: trimethoprim–sulfamethoxazole

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us